Harrow Inc (NAS:HROW)
$ 40.02 -1.84 (-4.4%) Market Cap: 1.43 Bil Enterprise Value: 1.61 Bil PE Ratio: 0 PB Ratio: 24.55 GF Score: 59/100

Q3 2020 Harrow Health Inc Earnings Call Transcript

Nov 09, 2020 / 09:45PM GMT
Release Date Price: $5.09 (+3.25%)
Operator

Good afternoon and welcome to the conference call covering Harrow Health's financial results and business update for the third quarter 2020. On the call joining me today, I have Harrow's chief executive officer, Mark Baum, and Harrow's chief financial officer, Andrew Boll. My name is Teran, and I'll be your operator for today's call.

(Operator Instructions) By now, you should have received a copy of the earnings press release. If you have not received a copy, please go to the investor relations page of the company's website at www.harrowinc.com.

Before we begin today, let me remind you that the company's remarks include forward-looking statements within the meaning of federal securities laws. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond Harrow Health's control, including risks and uncertainties described from time to time in its SEC filings, such as the risks and uncertainties related to the company's ability to make commercially available its compounded formulations

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot